133 related articles for article (PubMed ID: 17147223)
1. [Clinical study on pulmonary complications after allogeneic peripheral blood stem cell transplantation].
Zhang YZ; Da WM; Zhang BL; Gao CJ; Han XP; Huang WR; Jing Y; Li HH; Zhao Y; Bo J; Wang SH; Zhu HY; Jin HJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Jun; 27(6):366-9. PubMed ID: 17147223
[TBL] [Abstract][Full Text] [Related]
2. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
[TBL] [Abstract][Full Text] [Related]
3. Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation.
Patriarca F; Skert C; Sperotto A; Damiani D; Cerno M; Geromin A; Zaja F; Stocchi R; Prosdocimo S; Fili' C; Fanin R
Bone Marrow Transplant; 2004 Apr; 33(7):751-8. PubMed ID: 14755316
[TBL] [Abstract][Full Text] [Related]
4. T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome.
Montero A; Savani BN; Shenoy A; Read EJ; Carter CS; Leitman SF; Mielke S; Rezvani K; Childs R; Barrett AJ
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1318-25. PubMed ID: 17162214
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary complications occurring after allogeneic bone marrow transplantation].
Fan Y; Guo N; Huang X
Zhonghua Xue Ye Xue Za Zhi; 1998 Aug; 19(8):409-12. PubMed ID: 11189507
[TBL] [Abstract][Full Text] [Related]
6. Late-onset non-infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children.
Nishio N; Yagasaki H; Takahashi Y; Muramatsu H; Hama A; Tanaka M; Yoshida N; Watanabe N; Kudo K; Yoshimi A; Kojima S
Bone Marrow Transplant; 2009 Sep; 44(5):303-8. PubMed ID: 19349954
[TBL] [Abstract][Full Text] [Related]
7. The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors.
Pabst C; Schirutschke H; Ehninger G; Bornhäuser M; Platzbecker U
Clin Cancer Res; 2007 May; 13(10):2916-22. PubMed ID: 17504991
[TBL] [Abstract][Full Text] [Related]
8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of allogeneic peripheral blood stem cell transplantation in 23 patients with myelodysplastic syndromes].
Hu LD; Chen H; Jiang M; Li BT; Qin MQ; Yu ZY; Li YH
Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):522-4. PubMed ID: 17172124
[TBL] [Abstract][Full Text] [Related]
10. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
[TBL] [Abstract][Full Text] [Related]
11. [Late-onset noninfectious pulmonary complications after allogeneic peripheral blood stem cell transplantation].
Zhang YZ; Gao CJ; Zhang BL; DA WM; Han XP; Li HH; Jing Y; Huang WR; Bo J; Wang SH; Zhu HY; Jin HJ; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):632-5. PubMed ID: 17605882
[TBL] [Abstract][Full Text] [Related]
12. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH
Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
[TBL] [Abstract][Full Text] [Related]
13. [Non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation: analysis of 17 cases].
Xu D; Liu QF; Sun J; Fan ZP; Wei YQ; Zhang Y; Ye CX; Meng FY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):549-53. PubMed ID: 16681886
[TBL] [Abstract][Full Text] [Related]
14. Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect.
Sakaida E; Nakaseko C; Harima A; Yokota A; Cho R; Saito Y; Nishimura M
Blood; 2003 Dec; 102(12):4236-42. PubMed ID: 12907447
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
[TBL] [Abstract][Full Text] [Related]
16. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
17. Early renal injury after nonmyeloablative allogeneic peripheral blood stem cell transplantation in patients with chronic myelocytic leukemia.
Liu H; Ding JH; Liu BC; Zhao G; Chen BA
Am J Nephrol; 2007; 27(4):336-41. PubMed ID: 17519537
[TBL] [Abstract][Full Text] [Related]
18. B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation.
Iori AP; Torelli GF; De Propris MS; Milano F; Pupella S; Gozzer M; Mancini F; Milani ML; Intoppa S; Cerretti R; Lucarelli B; Valle V; Malandruccolo L; Iannella E; Arleo E; Guarini A; Foà R
Transplantation; 2008 Feb; 85(3):386-90. PubMed ID: 18322430
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of late onset non-infectious pulmonary complications following pediatric allogeneic hematopoietic stem cell transplantation.
Park M; Koh KN; Kim BE; Im HJ; Seo JJ
Clin Transplant; 2011; 25(2):E168-76. PubMed ID: 21077955
[TBL] [Abstract][Full Text] [Related]
20. Post-transplant infections: single center experience from the developing world.
Ullah K; Raza S; Ahmed P; Chaudhry QU; Satti TM; Ahmed S; Mirza SH; Akhtar F; Kamal K; Akhtar FM
Int J Infect Dis; 2008 Mar; 12(2):203-14. PubMed ID: 17920999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
